Your browser doesn't support JavaScript. Please upgrade to a modern browser or enable JavaScript in your existing browser.
Skip Navigation U.S. Department of Health and Human Services www.hhs.gov
Agency for Healthcare Research Quality www.ahrq.gov
www.ahrq.gov

Table 2.18
Percent of central vascular catheter placement with associated bloodstream infections or mechanical adverse events, United States, 2004a
    2004
Population group Exposed Adverse events Percent Standard error
Total 2576 76 3.0 0.3
Age Under 65 524 18 3.4 0.8
65-74 905 22 2.4 0.5
75-84 847 30 3.5 0.6
85 and over DSU DSU DSU DSU
Gender Female 1371 41 3.0 0.5
Male 1205 35 2.9 0.5
Race Black 368 14 3.8 1.0
Other DSU DSU DSU DSU
White 2068 57 2.8 0.4
Diabetes No 1524 37 2.4 0.4
Yes 1052 39 3.7 0.6
Obesity No 2117 64 3.0 0.4
Yes 459 12 2.6 0.7
Cerebrovascular disease No 1949 57 2.9 0.4
Yes 627 19 3.0 0.7
CHF/pulmonary edema No 1598 40 2.5 0.4
Yes 978 36 3.7 0.6
COPD No 1729 53 3.1 0.4
Yes 847 23 2.7 0.6
Smoking No 2113 57 2.7 0.4
Yes 463 19 4.1 0.9
Cancer No 1801 52 2.9 0.4
Yes 775 24 3.1 0.6
Corticosteroids No 2306 70 3.0 0.4
Yes DSU DSU DSU DSU
Coronary artery disease No 1200 35 2.9 0.5
Yes 1376 41 3.0 0.5
Renal disease No 1602 35 2.2 0.4
Yes 974 41 4.2 0.6

a Data include Medicare beneficiaries discharged from January to December. Readmissions are supposed to be counted in the numerators according to the measure specifications, but were not counted because the data were not available at this time.

DSU - Data do not meet the criteria for statistical reliability, data quality or confidentiality.

Key: CHF: congestive heart failure; COPD: chronic obstructive pulmonary disease.

Source: Centers for Medicare & Medicaid Services, Medicare Patient Safety Monitoring System.

Return to Contents

 

AHRQ Advancing Excellence in Health Care